Rosiglitazone Promotes Microglial Distribution via Activation of PPAR γ and CD36 in the ICH Rat Model
CONCLUSION: Rosiglitazone may improve microglial distribution via promoting the expression of PPARγ and CD36 around the hematoma in the ICH rat model, which may provide effective therapeutic targets for the treatment of ICH.PMID:38583188
Source: Neuroendocrinology Letters - Category: Endocrinology Authors: Qiong Mu Qian He Hailong Zhou Yingning Xu Guofeng Wu Source Type: research
More News: Avandia | Brain | Endocrinology | Hemorrhagic Stroke | International Medicine & Public Health | Neurology | Study